Capital World Investors Madrigal Pharmaceuticals, Inc. Transaction History

Capital World Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $6.97 Million - $15.8 Million	-73,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $11.8 Million - $17.1 Million	-57,000 Reduced 43.68%	73,500 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $7.46 Million - $23.1 Million	73,500 Added 128.95%	130,500 $36.5 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $5.32 Million - $8.5 Million	57,000 New	57,000 $6.66 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.